Form 4 for FLGT Fulgent Genetics, Inc.
Accepted 2021-11-18 00:00:00 ET · period of report 2021-11-16 · accession 0001209191-21-065526 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-18 | 2021-11-16 | FLGT | Xie Jian | COO | S - Sale | $95.50 | -1,214 | 303.3K | -0.4% | -$115.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-16 | S | D | 1,214 | $95.50 | 303,339 | D | — | — | (F1) The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on November 1, 2019. (F2) The shares were sold in multiple transactions at prices ranging from $95.3400 to $95.6200, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |